Passa al contenuto
Merck

Prevention of contrast-induced nephropathy: the rational use of sodium bicarbonate.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association (2007-09-26)
Reymond Barreto
ABSTRACT

The incidence of contrast-induced nephropathy (CIN) is increasing due to the growing number of patients undergoing radiocontrast studies. CIN is associated with a mortality rate as high as 34%. The purpose of this article is to review the strategies for preventing CIN and explore the role of sodium bicarbonate in this setting. A review of current literature suggests that prophylactic N-acetylcysteine and hydration with sodium bicarbonate may be the best pharmacological approach to preventing CIN. This article provides the dosing, administration, and monitoring guidelines for sodium bicarbonate, as well as implications for the nephrology nurse.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Bicarbonato di sodio, ACS reagent, ≥99.7%
Sigma-Aldrich
Bicarbonato di sodio, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Bicarbonato di sodio, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Sodium bicarbonate solution, solution (7.5%), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Bicarbonato di sodio, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Bicarbonato di sodio, BioXtra, 99.5-100.5%
USP
Bicarbonato di sodio, United States Pharmacopeia (USP) Reference Standard
Supelco
Sodium bicarbonate concentrate, 0.1 M NaHCO3 in water, eluent concentrate for IC
Sigma-Aldrich
Bicarbonato di sodio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Bicarbonato di sodio, −40-+140 mesh, ≥95%
Sigma-Aldrich
Bicarbonato di sodio, tested according to Ph. Eur.
Sigma-Aldrich
Sodium bicarbonate-12C, 99.9 atom % 12C